Market Overview

Feuerstein Not Excited About JPMorgan Biotech Conference

Feuerstein Not Excited About JPMorgan Biotech Conference

JPMorgan's Annual Healthcare Conference is one of the largest gathering of healthcare companies, executives, investors, and other stakeholders and kicks off on Monday.

Chris Lewis of Roth Capital Partners commented in a note on January 5 that he is expecting "a number of preannouncments" within the space. The analyst added that many companies are expected to issue preliminary fourth quarter 2015 results and/or 2016 guidance Monday morning.

Meanwhile, The Street's Adam Feuerstein, a notable biotech expert, thinks the sector's outlook is dire. On January 7, Feuerstein tweeted that 2016 will be a "bummer year" for biotech stocks.

Here are some of Feuerstein's other notable Tweets expressing his bearish outlook for the sector.

Posted-In: Adam Feurestein Chris Lewis JPMorgan Biotech ConferenceAnalyst Color News Short Ideas Previews Trading Ideas Best of Benzinga


Related Articles

View Comments and Join the Discussion!